Cullen Frost Bankers Inc. Buys 8,437 Shares of The Clorox Company $CLX

Cullen Frost Bankers Inc. grew its holdings in shares of The Clorox Company (NYSE:CLX) by 18.6% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 53,833 shares of the company’s stock after purchasing an additional 8,437 shares during the quarter. Cullen Frost Bankers Inc.’s holdings in Clorox were worth $6,464,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Fiduciary Family Office LLC boosted its position in Clorox by 4.3% during the second quarter. Fiduciary Family Office LLC now owns 5,059 shares of the company’s stock worth $607,000 after purchasing an additional 207 shares during the period. Liberty One Investment Management LLC boosted its position in Clorox by 11.5% during the second quarter. Liberty One Investment Management LLC now owns 224,873 shares of the company’s stock worth $27,000,000 after purchasing an additional 23,132 shares during the period. Triton Financial Group Inc bought a new position in Clorox during the second quarter worth about $869,000. Journey Advisory Group LLC boosted its position in Clorox by 22.1% during the second quarter. Journey Advisory Group LLC now owns 1,991 shares of the company’s stock worth $239,000 after purchasing an additional 360 shares during the period. Finally, Bogart Wealth LLC boosted its position in Clorox by 289.5% during the second quarter. Bogart Wealth LLC now owns 370 shares of the company’s stock worth $44,000 after purchasing an additional 275 shares during the period. Institutional investors own 78.53% of the company’s stock.

Clorox Trading Down 1.5%

CLX stock opened at $118.14 on Thursday. The company has a market capitalization of $14.39 billion, a PE ratio of 18.12, a price-to-earnings-growth ratio of 0.99 and a beta of 0.52. The Clorox Company has a one year low of $116.53 and a one year high of $171.37. The company’s 50 day moving average price is $121.41 and its two-hundred day moving average price is $127.30. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Thursday, July 31st. The company reported $2.87 EPS for the quarter, topping the consensus estimate of $2.24 by $0.63. The firm had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $1.94 billion. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The business’s revenue was up 4.5% compared to the same quarter last year. During the same period last year, the firm posted $1.82 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. As a group, analysts predict that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, November 6th. Investors of record on Wednesday, October 22nd will be paid a $1.24 dividend. This represents a $4.96 annualized dividend and a dividend yield of 4.2%. The ex-dividend date of this dividend is Wednesday, October 22nd. Clorox’s payout ratio is presently 76.07%.

Insider Activity at Clorox

In related news, COO Eric H. Reynolds sold 15,041 shares of Clorox stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total value of $1,861,774.98. Following the transaction, the chief operating officer directly owned 54,221 shares of the company’s stock, valued at $6,711,475.38. The trade was a 21.72% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.63% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

CLX has been the subject of a number of research reports. JPMorgan Chase & Co. cut their target price on shares of Clorox from $135.00 to $127.00 and set a “neutral” rating for the company in a research report on Friday, October 10th. Citigroup cut their price target on shares of Clorox from $135.00 to $130.00 and set a “neutral” rating for the company in a report on Wednesday, October 8th. Wells Fargo & Company cut their price target on shares of Clorox from $130.00 to $125.00 and set an “equal weight” rating for the company in a report on Thursday, September 25th. Jefferies Financial Group cut their price target on shares of Clorox from $167.00 to $145.00 and set a “buy” rating for the company in a report on Thursday, June 26th. Finally, Morgan Stanley cut their price target on shares of Clorox from $150.00 to $137.00 and set an “equal weight” rating for the company in a report on Friday, August 1st. One analyst has rated the stock with a Buy rating, twelve have assigned a Hold rating and four have given a Sell rating to the company. Based on data from MarketBeat, Clorox has an average rating of “Reduce” and an average target price of $130.20.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.